Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...
Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...
Fibroblast growth factor receptors (FGFRs) are critical drivers of oncogenesis in various solid tumors, including urothelial carcinoma, hepatocellular ...
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
A fit retired firefighter who went to see the doctor with a cough he couldn't shackle was told he had lung cancer - and died ...
We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before ...
The study suggests that air pollution is a major factor behind the rise in adenocarcinoma cases among non-smokers. Polluted air contains fine particulate matter (PM2.5), nitrogen dioxide (NO2), and ...
12h
Stocktwits on MSNCandel Therapeutics Stock Headed For 20% Weekly Gains: Retail Over The Moon With BofA's 'Buy' CallShares of Candel Therapeutics Inc. (CADL) surged over 9% on Friday morning, reaching their highest level in nearly a month ...
One key subtype of lung cancer - adenocarcinoma - has become predominant among women in 185 countries, the authors wrote in ...
Wells Fargo (NYSE:WFC) initiated coverage on Merus N.V. (NASDAQ:MRUS), currently trading at $41.54 with a market capitalization of $2.84 billion, with an Overweight rating and a price target of $91.00 ...
Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results